about
Molecular diagnosis of putative Stargardt disease by capture next generation sequencingCRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool.Recapitulating and Correcting Marfan Syndrome in a Cellular Model.Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells.Deciphering relationship between microhomology and in-frame mutation occurrence in human CRISPR-based gene knockoutCRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells.Questions about NgAgo.A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.Recapitulating X-Linked Juvenile Retinoschisis in Mouse Model by Knock-In Patient-Specific Novel Mutation.SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells.Photoreceptor Cell-Derived CAPN5 Regulates Retinal Pigment Epithelium Cell Proliferation Through Direct Regulation of SLIT2 Cleavage.DeepCRISPR: optimized CRISPR guide RNA design by deep learning.A Single Multiplex crRNA Array for FnCpf1-Mediated Human Genome EditingFunctional non-homologous end joining patterns triggered by CRISPR/Cas9 in human cellsBasic and Clinical Application of Adeno-Associated Virus-Mediated Genome EditingEfficient cleavage resolves PAM preferences of CRISPR-Cas in human cellsEfficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes
P50
Q28538229-961F3C73-6D80-4CC4-9673-7F2B57CD55A9Q33676110-6B9A4ED7-C1A2-4DEE-89BD-4C7B3D98D708Q33717760-BDEAA392-2550-4C28-A6EA-C33AFA61EA46Q33791002-65B14A9E-B7B0-4B1E-86ED-B68F27AEBCC6Q37254634-DBD7FB1C-C63E-4A9A-B30B-4FB4A49BFBEEQ37501558-B5A0C6E4-DCA1-4952-B1A7-6E3832225728Q42335525-031E6BDA-0FDF-4391-B213-D86145BD322FQ47601711-7A5E7EAC-F5FE-4998-BC4C-8FB835C48E15Q48509694-8FE0E02B-9D76-45B6-826A-2EE734507D4CQ49787044-1BFBFFED-910F-4AEC-B335-935B6BA37C4DQ52611323-9FE852CD-C107-4F09-B1DE-46EAF4105399Q55513041-2F4A85E1-C6F9-4EC1-BC9D-1C415D4D0DA9Q89129497-7A11C069-ECFF-4E72-A05E-F4A6DC215E62Q89180569-024E80D9-CA03-4E98-8205-ABA03D189AC7Q90770347-7A2D8F93-C7CD-4D59-847B-814A5800D87CQ91218727-C1692063-9E2A-400D-B9BD-13E3C965C47BQ92712123-C605C4DA-1372-412D-847D-E00F78CE886F
P50
description
researcher (ORCID 0000-0002-9600-8407)
@en
name
Feng Gu
@en
type
label
Feng Gu
@en
prefLabel
Feng Gu
@en
P31
P496
0000-0002-9600-8407